Correale J, Chiquete E, Boyko A, Beran RG, Strauch JB, Milojevic S, & Frider N. (2016). Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: Focus on fingolimod. Dove Medical Press.
Chicago Style (17th ed.) CitationCorreale J, Chiquete E, Boyko A, Beran RG, Strauch JB, Milojevic S, and Frider N. Clinical Implications for Substandard, Nonproprietary Medicines in Multiple Sclerosis: Focus on Fingolimod. Dove Medical Press, 2016.
MLA (9th ed.) CitationCorreale J, et al. Clinical Implications for Substandard, Nonproprietary Medicines in Multiple Sclerosis: Focus on Fingolimod. Dove Medical Press, 2016.
Warning: These citations may not always be 100% accurate.